Dabigatran-related coagulopathy: when can we assume the effect has "worn off"?

Am J Emerg Med. 2014 Nov;32(11):1433-4. doi: 10.1016/j.ajem.2014.08.072. Epub 2014 Aug 29.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antithrombins / adverse effects*
  • Atrial Fibrillation / drug therapy*
  • Benzimidazoles / adverse effects*
  • Dabigatran
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Male
  • Stroke / drug therapy*
  • Tissue Plasminogen Activator / therapeutic use*
  • beta-Alanine / adverse effects
  • beta-Alanine / analogs & derivatives*

Substances

  • Antithrombins
  • Benzimidazoles
  • Fibrinolytic Agents
  • beta-Alanine
  • Tissue Plasminogen Activator
  • Dabigatran